College of Pharmacy, South-Central University for Nationalities, Wuhan 430074, PR China.
J Ethnopharmacol. 2013 Oct 7;149(3):729-36. doi: 10.1016/j.jep.2013.07.035. Epub 2013 Aug 7.
Sanguis draxonis (SD) is a kind of red resin obtained from the wood of Dracaena cochinchinensis (Lour.) S. C. Chen (Dracaena cochinchinensis). It is a Chinese traditional herb that is prescribed for the handling of diabetic disorders, which is also supported by an array of scientific studies published in recent years. Although chemical constituents of this plant material have also been previously evaluated (Tang et al., 1995; Wei et al., 1998), it still remains poorly understood which constituent is the major contributor to its antidiabetic activities. Moreover, very little is known about the molecular mechanisms underlying antidiabetic activities of SD. Flavonoids exist at a high level in SD. The aim of this study is to evaluate the antidiabetic effects of total flavonoids from SD (SDF) in type 2 Diabetes mellitus (T2DM) rats.
T2DM rats were induced by 4 weeks high-fat diet and a singular injection of streptozotocin (STZ) (35mg/kg). Then T2DM rats were treated with SDF for 21 days, using normal saline as the negative control. For comparison, a standard antidiabetic drug, metformin (200mg/kg), was used as a positive control. Three weeks later, relative biochemical indexes were determined and histopathological examinations were performed to assess the antidiabetic activities of SDF.
SDF not only exhibited a significant hypoglycemic activity, but also alleviated dyslipidemia, tissue steatosis, and oxidative stress associated with T2DM. Moreover, considerable pancreatic islet protecting effects could be observed after SDF treatment. Further investigations revealed a potential anti-inflammation activity of SDF by determining serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP).
This study demonstrates both hypoglycemic and hypolipidemic effects of SDF in T2DM rats, suggesting that flavonoids are the major active ingredients accounting for the antidiabetic activity of SD. Alleviating chronic inflammation responses and protecting pancreatic islets are possible mechanisms involved in the antidiabetic activity of SDF.
血竭(SD)是从龙舌兰科龙血树(Dracaena cochinchinensis)(龙舌兰科)的木材中提取的一种红色树脂。它是一种传统的中药,用于治疗糖尿病,近年来也有大量科学研究支持这一观点。尽管该植物材料的化学成分以前也有过评估(Tang 等人,1995;Wei 等人,1998),但仍不清楚哪种成分是其抗糖尿病活性的主要贡献者。此外,关于 SD 的抗糖尿病活性的分子机制知之甚少。黄酮类化合物在 SD 中含量很高。本研究旨在评估 SD 总黄酮(SDF)在 2 型糖尿病(T2DM)大鼠中的抗糖尿病作用。
T2DM 大鼠通过 4 周高脂肪饮食和单次链脲佐菌素(STZ)(35mg/kg)注射诱导。然后,T2DM 大鼠用 SDF 治疗 21 天,以生理盐水作为阴性对照。为了比较,使用标准抗糖尿病药物二甲双胍(200mg/kg)作为阳性对照。3 周后,测定相关生化指标,并进行组织病理学检查,以评估 SDF 的抗糖尿病活性。
SDF 不仅表现出显著的降血糖作用,而且还缓解了与 T2DM 相关的血脂异常、组织脂肪变性和氧化应激。此外,SDF 治疗后可观察到胰岛的显著保护作用。进一步的研究通过测定血清白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和 C 反应蛋白(CRP)水平,发现 SDF 具有潜在的抗炎活性。
本研究表明 SDF 在 T2DM 大鼠中具有降血糖和降血脂作用,提示黄酮类化合物是 SD 抗糖尿病活性的主要活性成分。缓解慢性炎症反应和保护胰岛是 SDF 抗糖尿病活性的可能机制。